OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
0.0390
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
OpGen Company Description
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits.
It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services.
OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
OpGen, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 93 |
| CEO | Honjian Tan |
Contact Details
Address: 9717 Key West Avenue Rockville, Delaware 20850 United States | |
| Phone | 240 813 1260 |
| Website | opgen.com |
Stock Details
| Ticker Symbol | OPGN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US68373L3078 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Honjian Tan | Chief Executive Officer and Chairman |
| Dr. Oliver Schacht Ph.D. | Executive Vice President of Corporate Development |
| David Elliot Lazar | President |
| David Caplon | Corporate Controller |
| Mohd Azham Azudin | Chief Operating Officer |
| Rou Yee Tan | Company Secretary |